Jane Street Group, LLC Travere Therapeutics, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 311,260 shares of TVTX stock, worth $5.52 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

311,260

Previous 409,857 24.06%

Holding current value

$5.52 Million

Previous $3.37 Million 29.24%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$7.89 - $15.21 $777,930 - $1.5 Million	-98,597 Reduced 24.06%	311,260 $4.35 Million
Q2 2024 Aug 14, 2024	BUY	$5.26 - $8.28 $108,613 - $170,973	20,649 Added 5.31%	409,857 $3.37 Million
Q1 2024 May 15, 2024	BUY	$7.18 - $9.82 $984,435 - $1.35 Million	137,108 Added 54.39%	389,208 $3 Million
Q4 2023 Feb 14, 2024	BUY	$5.44 - $9.5 $459,973 - $803,263	84,554 Added 50.47%	252,100 $2.27 Million
Q3 2023 Nov 14, 2023	BUY	$7.64 - $17.25 $760,638 - $1.72 Million	99,560 Added 146.44%	167,546 $1.5 Million
Q2 2023 Aug 14, 2023	SELL	$15.3 - $22.61 $2.65 Million - $3.92 Million	-173,258 Reduced 71.82%	67,986 $1.04 Million
Q1 2023 May 15, 2023	BUY	$17.82 - $22.89 $4.3 Million - $5.52 Million	241,244 New	241,244 $5.43 Million
Q2 2022 Aug 16, 2022	BUY	$20.94 - $30.01 $374,616 - $536,878	17,890 Added 177.06%	27,994 $678,000
Q4 2021 Feb 15, 2022	SELL	$24.34 - $31.17 $7,642 - $9,787	-314 Reduced 3.01%	10,104 $314,000
Q3 2021 Nov 16, 2021	SELL	$12.98 - $25.03 $759,667 - $1.46 Million	-58,526 Reduced 84.89%	10,418 $253,000
Q2 2021 Aug 16, 2021	BUY	$14.11 - $26.4 $837,216 - $1.57 Million	59,335 Added 617.49%	68,944 $1.01 Million
Q1 2021 May 18, 2021	SELL	$23.37 - $31.77 $223,604 - $303,975	-9,568 Reduced 49.89%	9,609 $240,000
Q4 2020 Feb 17, 2021	BUY	$19.17 - $27.87 $367,623 - $534,462	19,177 New	19,177 $523,000

Others Institutions Holding TVTX

# of Institutions

192

Shares Held

84.5M

Call Options Held

776K

Put Options Held

900K

View Full List

About Travere Therapeutics, Inc.

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.14B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

More about TVTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Travere Therapeutics, Inc. Transaction History